BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1164 related articles for article (PubMed ID: 24946958)

  • 81. Percutaneous radiofrequency ablation for renal cell carcinoma vs. partial nephrectomy: Comparison of long-term oncologic outcomes in both clear cell and non-clear cell of the most common subtype.
    Liu N; Huang D; Cheng X; Chong Y; Wang W; Gan W; Guo H
    Urol Oncol; 2017 Aug; 35(8):530.e1-530.e6. PubMed ID: 28408296
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.
    Yang R; Lian H; Zhang G; Wang W; Gan W; Li X; Yan X; Zhang S; Zhao X; Guo H
    J Endourol; 2014 Jan; 28(1):4-9. PubMed ID: 23998802
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Radiofrequency ablation of invasive breast carcinoma followed by delayed surgical excision.
    Burak WE; Agnese DM; Povoski SP; Yanssens TL; Bloom KJ; Wakely PE; Spigos DG
    Cancer; 2003 Oct; 98(7):1369-76. PubMed ID: 14508822
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Surgical resection versus radiofrequency ablation for small hepatocellular carcinomas within the Milan criteria.
    Ueno S; Sakoda M; Kubo F; Hiwatashi K; Tateno T; Baba Y; Hasegawa S; Tsubouchi H;
    J Hepatobiliary Pancreat Surg; 2009; 16(3):359-66. PubMed ID: 19300896
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Oncologic Efficacy of Radio Frequency Ablation for Small Renal Masses: Clear Cell vs Papillary Subtype.
    Lay AH; Faddegon S; Olweny EO; Morgan M; Lorber G; Trimmer C; Leveillee R; Cadeddu JA; Gahan JC
    J Urol; 2015 Sep; 194(3):653-7. PubMed ID: 25846416
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
    Blute ML; Amling CL; Bryant SC; Zincke H
    Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up.
    Arzola J; Baughman SM; Hernandez J; Bishoff JT
    Urology; 2006 Nov; 68(5):983-7. PubMed ID: 17095059
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Radiofrequency ablation of renal tumours with clinical, radiographical and pathological results.
    Karam JA; Ahrar K; Vikram R; Romero CA; Jonasch E; Tannir NM; Rao P; Wood CG; Matin SF
    BJU Int; 2013 May; 111(6):997-1005. PubMed ID: 23510233
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Is radiofrequency ablation safe for solitary kidneys?
    Jacobsohn KM; Ahrar K; Wood CG; Matin SF
    Urology; 2007 May; 69(5):819-23; discussion 823. PubMed ID: 17482911
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Radio-frequency ablation of renal cell carcinoma in patients who were at significant risk.
    Ukimura O; Kawauchi A; Fujito A; Mizutani Y; Okihara K; Mikami K; Soh J; Nakamura T; Nakanishi H; Ushijima S; Miki T
    Int J Urol; 2004 Dec; 11(12):1051-7. PubMed ID: 15663674
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Percutaneous cryoablation of stage T1b renal cell carcinoma: technique considerations, safety, and local tumor control.
    Atwell TD; Vlaminck JJ; Boorjian SA; Kurup AN; Callstrom MR; Weisbrod AJ; Lohse CM; Hartman WR; Stockland AH; Leibovich BC; Schmit GD; Thompson RH
    J Vasc Interv Radiol; 2015 Jun; 26(6):792-9. PubMed ID: 25824313
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Ultrasound-guided transhepatic radiofrequency ablation of renal tumors: a safe and effective approach.
    Hegg RM; Schmit GD; Kurup AN; Weisbrod AJ; Boorjian SA; Atwell TD
    Cardiovasc Intervent Radiol; 2014 Apr; 37(2):508-12. PubMed ID: 23934115
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy of imaging-guided percutaneous radiofrequency ablation for the treatment of biopsy-proven malignant cystic renal masses.
    Felker ER; Lee-Felker SA; Alpern L; Lu D; Raman SS
    AJR Am J Roentgenol; 2013 Nov; 201(5):1029-35. PubMed ID: 24147473
    [TBL] [Abstract][Full Text] [Related]  

  • 97. CT-guided bipolar and multipolar radiofrequency ablation (RF ablation) of renal cell carcinoma: specific technical aspects and clinical results.
    Sommer CM; Lemm G; Hohenstein E; Bellemann N; Stampfl U; Goezen AS; Rassweiler J; Kauczor HU; Radeleff BA; Pereira PL
    Cardiovasc Intervent Radiol; 2013 Jun; 36(3):731-7. PubMed ID: 22926302
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Radiofrequency ablation for the treatment of small renal masses: safety and oncologic efficacy.
    Joniau S; Tsivian M; Gontero P
    Minerva Urol Nefrol; 2011 Sep; 63(3):227-36. PubMed ID: 21993321
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
    Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
    Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.